CRISPR Technique Targets GGC Repeat Expansions in NOTCH2NLC Gene to Address Neuronal Intranuclear Inclusion Disease

Researchers have developed a CRISPR/Cas9-based technique to target and remove pathogenic nucleotide expansions in the NOTCH2NLC gene, a breakthrough that could lead to new treatments for neuronal intranuclear inclusion disease (NIID). NIID is a neurodegenerative disorder marked by the buildup of toxic nuclear inclusions and progressive loss of neurons. This innovative approach focuses on excising GGC repeat expansions within the gene, which are believed to play a central role in the development of the disease.

The study highlights how this precise gene-editing method addresses the underlying genetic cause of NIID by targeting specific DNA sequences. By removing these harmful expansions, researchers aim to mitigate the toxic effects associated with their presence. The findings represent significant progress in applying CRISPR technology to treat complex neurological conditions. Further research will likely focus on refining this strategy and evaluating its safety and efficacy in clinical settings.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 13, 2026

Author

GOAI